AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Sep 12, 2024
32559_dirs_2024-09-11_35b1372b-cbb7-484e-81d9-243eedca283f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-09-09
Reporting Person: Quigley Jill M. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-09 | Common Stock | M | 17235.00 | $1.82 | Acquired | 32235.00 | Direct |
| 2024-09-09 | Common Stock | S | 17235.00 | $10.00 | Disposed | 15000.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-09 | Stock Option (Right to Buy) | $1.82 | M | 17235.00 | Disposed | 2032-06-15 | Common Stock (17235.00) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
F2: The option vested in full immediately prior to the Annual Meeting following the date of grant.